Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Arsenic Trioxide × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Carcinoma, Basal Cell 2 Burkitt Lymphoma 2 Blast Crisis 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Sezary Syndrome 1 Myelodysplastic Syndromes 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Monocytic, Acute 1

Interventions

pembrolizumab 23 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 Interleukin-2 15 fludarabine 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Surgical Procedures, Operative 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 encorafenib 4 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01791894 2018-06-08

ATO

Stanford University

Phase 1/2 Completed

5 enrolled 9 charts

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡